Found: 29
Select item for more details and to access through your institution.
Modeling effects of dexamethasone on disease progression of bone mineral density in collagen-induced arthritic rats.
- Published in:
- Pharmacology Research & Perspectives, 2015, v. 3, n. 5, p. 1, doi. 10.1002/prp2.169
- By:
- Publication type:
- Article
Utility of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies: a viewpoint from the FDA.
- Published in:
- 2023
- By:
- Publication type:
- Letter
FDA-Industry Scientific Exchange on assessing quantitative systems pharmacology models in clinical drug development: a meeting report, summary of challenges/gaps, and future perspective.
- Published in:
- AAPS Journal, 2021, v. 23, n. 3, p. 1, doi. 10.1208/s12248-021-00585-x
- By:
- Publication type:
- Article
Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.
- Published in:
- AAPS Journal, 2019, v. 21, n. 4, p. N.PAG, doi. 10.1208/s12248-019-0339-5
- By:
- Publication type:
- Article
Therapeutic Protein Drug-Drug Interactions: Navigating the Knowledge Gaps-Highlights from the 2012 AAPS NBC Roundtable and IQ Consortium/FDA Workshop.
- Published in:
- 2013
- By:
- Publication type:
- Report
Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 3, p. 415, doi. 10.1007/s00262-008-0567-5
- By:
- Publication type:
- Article
Reply to White et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Effect of Body Weight and Age on the Pharmacokinetics of Dihydroartemisinin: Food and Drug Administration Basis for Dose Determination of Artesunate for Injection in Pediatric Patients With Severe Malaria.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 5, p. 903, doi. 10.1093/cid/ciab149
- By:
- Publication type:
- Article
Creating a Roadmap to Quantitative Systems Pharmacology–Informed Rare Disease Drug Development: A Workshop Report.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 2, p. 201, doi. 10.1002/cpt.3096
- By:
- Publication type:
- Article
Model‐Informed Drug Development Approaches to Assist New Drug Development in the COVID‐19 Pandemic.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 3, p. 572, doi. 10.1002/cpt.2491
- By:
- Publication type:
- Article
Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ Dysfunction.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 3, p. 624, doi. 10.1002/cpt.2445
- By:
- Publication type:
- Article
A Simulation Approach to Evaluate the Impact of Patterns of Bioanalytical Bias Difference on the Outcome of Pharmacokinetic Similarity Studies.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 1, p. 107, doi. 10.1002/cpt.1767
- By:
- Publication type:
- Article
Down-regulation of heat shock protein 70 improves arsenic trioxide and 17-DMAG effects on constitutive signal transducer and activator of transcription 3 activity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 4, p. 681, doi. 10.1007/s00280-009-1210-7
- By:
- Publication type:
- Article
Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 12, p. 1479, doi. 10.1002/psp4.12709
- By:
- Publication type:
- Article
Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 9, p. 973, doi. 10.1002/psp4.12681
- By:
- Publication type:
- Article
A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 12, p. 675, doi. 10.1002/psp4.12567
- By:
- Publication type:
- Article
Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions.
- Published in:
- Clinical Pharmacokinetics, 2011, v. 50, n. 10, p. 627, doi. 10.2165/11593210-000000000-00000
- By:
- Publication type:
- Article
Utility of population pharmacokinetic modeling in the assessment of therapeutic protein-drug interactions.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 5, p. 593, doi. 10.1002/jcph.240
- By:
- Publication type:
- Article
Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2016, v. 43, n. 2, p. 123, doi. 10.1007/s10928-016-9464-2
- By:
- Publication type:
- Article
Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-Response.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Application of Model‐Informed Drug Development in Dose Selection and Optimization for siRNA Therapies.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 7, p. 799, doi. 10.1002/jcph.2418
- By:
- Publication type:
- Article
Model‐Informed Approaches to Support Drug Development for Patients With Obesity: A Regulatory Perspective.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, p. S65, doi. 10.1002/jcph.2349
- By:
- Publication type:
- Article
Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development Program.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 259, doi. 10.1002/jcph.2158
- By:
- Publication type:
- Article
Model‐Informed Drug Development in Pediatric Dose Selection.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, p. S60, doi. 10.1002/jcph.1848
- By:
- Publication type:
- Article
Role of Model‐Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, p. S104, doi. 10.1002/jcph.1478
- By:
- Publication type:
- Article
Role of Model‐Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, p. S104, doi. 10.1002/jcph.1478
- By:
- Publication type:
- Article
The Utility of a Population Approach in Drug-Drug Interaction Assessments: A Simulation Evaluation.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 10, p. 1268, doi. 10.1002/jcph.921
- By:
- Publication type:
- Article
PK in Late Phase Trials.
- Published in:
- Applied Clinical Trials, 2012, v. 21, n. 2, p. 40
- By:
- Publication type:
- Article
Quantitative Dynamic Models of Arthritis Progression in the Rat.
- Published in:
- Pharmaceutical Research, 2009, v. 26, n. 1, p. 196, doi. 10.1007/s11095-008-9711-3
- By:
- Publication type:
- Article